ESTA Stock Overview
A medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Establishment Labs Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$41.59 |
| 52 Week High | US$60.12 |
| 52 Week Low | US$16.96 |
| Beta | 1.21 |
| 11 Month Change | 0.24% |
| 3 Month Change | -14.19% |
| 1 Year Change | -22.97% |
| 33 Year Change | -42.95% |
| 5 Year Change | 98.62% |
| Change since IPO | 68.04% |
Recent News & Updates
Recent updates
Earnings Release: Here's Why Analysts Cut Their Establishment Labs Holdings Inc. (NASDAQ:ESTA) Price Target To US$59.86
Aug 11
Shareholders Should Be Pleased With Establishment Labs Holdings Inc.'s (NASDAQ:ESTA) Price
Jul 23Establishment Labs: Catalysts Supporting A Perky Outlook
Jan 28Is Establishment Labs Holdings (NASDAQ:ESTA) A Risky Investment?
Dec 08Is Establishment Labs Holdings (NASDAQ:ESTA) Using Too Much Debt?
Aug 10Shareholders Should Be Pleased With Establishment Labs Holdings Inc.'s (NASDAQ:ESTA) Price
Apr 17Establishment Labs Holdings (NASDAQ:ESTA) Is Carrying A Fair Bit Of Debt
Dec 14Establishment Labs drops 18% after new short report from Hindenburg Research
Oct 19Establishment Labs: Flat Earnings, Return On Investment Keep Buyers At Bay
Sep 24Establishment Labs Holdings (NASDAQ:ESTA) Is Carrying A Fair Bit Of Debt
Sep 04Establishment Labs started at buy at B Riley on breast implants
Aug 24Health Check: How Prudently Does Establishment Labs Holdings (NASDAQ:ESTA) Use Debt?
Feb 23Is Establishment Labs Holdings (NASDAQ:ESTA) Using Debt Sensibly?
Sep 25Shareholder Returns
| ESTA | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -9.2% | -1.4% | -4.4% |
| 1Y | -23.0% | 14.0% | 19.1% |
Return vs Industry: ESTA underperformed the US Medical Equipment industry which returned 14% over the past year.
Return vs Market: ESTA underperformed the US Market which returned 19.1% over the past year.
Price Volatility
| ESTA volatility | |
|---|---|
| ESTA Average Weekly Movement | 8.7% |
| Medical Equipment Industry Average Movement | 8.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ESTA's share price has been volatile over the past 3 months.
Volatility Over Time: ESTA's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 857 | Juan Chacon Quiros | www.establishmentlabs.com |
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.
Establishment Labs Holdings Inc. Fundamentals Summary
| ESTA fundamental statistics | |
|---|---|
| Market cap | US$1.16b |
| Earnings (TTM) | -US$83.20m |
| Revenue (TTM) | US$151.35m |
7.7x
P/S Ratio-14.0x
P/E RatioIs ESTA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ESTA income statement (TTM) | |
|---|---|
| Revenue | US$151.35m |
| Cost of Revenue | US$51.40m |
| Gross Profit | US$99.95m |
| Other Expenses | US$183.15m |
| Earnings | -US$83.20m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.98 |
| Gross Margin | 66.04% |
| Net Profit Margin | -54.97% |
| Debt/Equity Ratio | 430.3% |
How did ESTA perform over the long term?
See historical performance and comparison